ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
NICE recommends NHS use of Kymriah for second indication
February 03, 2019The UK’s pricing regulator the National Institute for Health and Care Excellence (NICE) has recommended Novartis’ CAR-T therapy Kymriah (tisagenlecleucel) for use by the National Health Service (NHS) -
Predictions of early responses in paediatric acute lymphoblastic leukaemia
December 17, 2018Researchers have identified markers of pediatric acute lymphoblastic leukaemia to predict early relapses by testing levels of nucleotide excision repair…
Pharma Sources Insight January 2025
